Zhong Ji Longevity Science Group Limited (0767.HK) Plunges 20% on Profitability Concerns

Zhong Ji Longevity Science Group Limited (0767.HK) has become one of the Hong Kong stock market’s biggest losers, with shares plummeting 20% to HK$0.38 in today’s pre-market session. The sharp decline reflects mounting concerns about the company’s profitability and operational performance. Trading on the HKSE, the financial services and healthcare company faces significant headwinds from negative earnings and deteriorating fundamentals. Meyka AI’s analysis reveals deep structural challenges that have prompted a Sell rating on the stock.

Why 0767.HK Stock Is Crashing Today

The 20% drop in 0767.HK reflects a confluence of negative factors weighing on investor sentiment. The company reported a negative EPS of -0.03, signaling ongoing losses that undermine shareholder value. Meyka AI rates 0767.HK with a grade of C with a Sell recommendation, citing weak profitability metrics across multiple dimensions.

Key financial metrics paint a troubling picture. The stock’s price-to-earnings ratio stands at -15.0, indicating the company is unprofitable. Return on equity (ROE) is deeply negative at -4.17%, while return on assets (ROA) sits at -3.35%, both flagged as Strong Sell signals by Meyka’s proprietary scoring system. The company’s net profit margin of -10.19% shows it loses money on every dollar of revenue generated.

Technical Breakdown and Price Action

0767.HK trades significantly below its key moving averages, with the stock positioned at HK$0.38 below its 50-day average of HK$0.4764 and 200-day average of HK$0.5239. The relative strength index (RSI) at 38.24 suggests oversold conditions, though this has not arrested the selling pressure.

Volume remains subdued at 630,000 shares, representing just 33.76% of the stock’s average daily volume of 681,082 shares. This thin trading amplifies price swings and reduces liquidity for investors seeking exits. The stock has declined 10.23% over one day and 17.71% over five days, reflecting accelerating downward momentum. Year-to-date, 0767.HK has lost 21% of its value, underperforming the broader Financial Services sector.

Operational and Financial Challenges

Zhong Ji Longevity Science Group Limited operates across money lending, healthcare diagnostics, and medical product distribution in Hong Kong and Mainland China. However, operational metrics reveal significant inefficiencies. Days sales outstanding (DSO) stands at an alarming 970.2 days, indicating the company struggles to collect receivables from customers or lending clients.

The company’s current ratio of 87.55 appears strong on the surface, but masks underlying cash flow problems. Operating cash flow per share is -0.0259, and free cash flow per share is -0.0259, both negative. With a market cap of HK$286.5 million and only 55 full-time employees, the company lacks scale to compete effectively. Track 0767.HK on Meyka for real-time updates on this deteriorating situation.

Meyka AI Price Forecast and Valuation

Meyka AI’s forecast model projects 0767.HK could reach HK$0.48 within one year, implying 26.3% upside from current levels. However, this forecast assumes operational stabilization that remains uncertain. The three-year target of HK$0.92 suggests recovery potential, but requires significant turnaround execution.

The stock trades at a price-to-book ratio of 0.78, suggesting modest discount to tangible book value of HK$0.54 per share. However, negative earnings and cash flow generation make traditional valuation metrics unreliable. The company’s enterprise value of HK$232.7 million reflects minimal investor confidence in its business model and growth prospects.

Final Thoughts

Zhong Ji Longevity Science Group’s 20% stock crash reflects legitimate concerns about profitability and cash flow. The company shows negative earnings, weak returns on equity and assets, and poor receivables collection. Meyka AI rates it C grade with a Sell recommendation due to weak fundamentals across all metrics. Despite trading below book value, the discount does not offset the company’s inability to generate profits or positive cash flow. Investors should avoid the stock until management demonstrates concrete operational improvements and a credible path to profitability.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.